Latest news releases

View all releases

Gavi welcomes recommendation to include existing Ebola vaccine Ervebo in clinical trials for Bundibugyo virus disease

Gavi, the Vaccine Alliance welcomes the news that the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo virus disease (BVD) outbreak response recommends that the existing approved Ebola vaccine.

Gavi welcomes United States government commitment to unlock funding for fiscal years 2025 and 2026

Gavi, the Vaccine Alliance welcomes the announcement today by the United States Government that it intends to release US$ 600 million in funding appropriated by Congress for Gavi for fiscal years 2025 and 2026.

Strong progress in lower-income countries underscores need for sustained investment in immunisation

Each year WHO and UNICEF release global and national routine immunisation coverage estimates (WUENIC). Immunisation in the lowest-income countries is supported by Gavi, the Vaccine Alliance – a partnership that helps vaccinate more than half the…

Gavi for the media

Gavi for the media

Visit our dedicated media room to see our latest press releases and statements, updated key facts and figures, as well as contact details for our media team.

Gavi/Frederique Tissandier

Latest publications

View all reports

Gavi Progress Report 2024

Welcome to Gavi’s 2024 Annual Progress Report, the fourth of the 2021–2025 strategic period.

Gavi Progress Report 2023

Welcome to Gavi’s 2023 Annual Progress Report, the third of the 2021–2025 strategic period.

Last updated: 18 Feb 2026